Korro Bio, Inc. (KRRO) income statement
KRRONasdaqPharmaceutical PreparationsFiscal year ends December 31
$12.18−0.01 (-0.08%)
Close on Nov 20, 2026Market cap $179.36MP/E –Yield –
Korro Bio, Inc. financial ratios
See a number that looks wrong?
Close on Nov 20, 2026Market cap $179.36MP/E –Yield –
See a number that looks wrong?
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Margins | ||||||||||
| Operating margin | -1,906.4% | -4,047.1% | – | – | -597.3% | -74.5% | -71.4% | – | – | – |
| Pre-tax margin | -1,824.5% | -3,674.2% | – | – | -601.9% | -71.6% | -64.8% | – | – | – |
| Net profit margin | -1,834.5% | -3,680.4% | – | – | -602.0% | -71.7% | -64.8% | – | – | – |
| Free cash flow margin | -1,237.2% | -3,433.6% | – | – | -561.4% | -140.2% | 114.5% | – | – | – |
| Returns on capital | ||||||||||
| Return on equity | -110.7% | -50.6% | -229.0% | 82.2% | -112.7% | -14.7% | -33.3% | 49.2% | 103.0% | – |
| Return on assets | -69.0% | -37.3% | -55.0% | -44.8% | -37.6% | -10.9% | -14.0% | -43.0% | – | – |
| Return on tangible assets | -69.0% | -37.3% | -55.0% | -44.8% | -37.6% | -10.9% | -14.0% | -43.0% | – | – |
| Return on invested capital | – | – | – | 29.5% | 38.6% | – | 23.3% | 16.6% | – | – |
| Return on capital employed | -77.9% | -44.5% | -63.3% | -49.4% | -40.8% | -13.5% | -19.6% | -46.5% | – | – |
| Return on total capital | – | – | – | 90.5% | 203.1% | – | -34.6% | 39.5% | – | – |
| NOPAT | -$96.27M | -$72.61M | -$66.78M | -$46.61M | -$66.38M | -$21.76M | -$16.33M | -$14.97M | -$12.88M | – |
| Cash flow quality | ||||||||||
| OCF / Sales | -1,229.1% | -2,645.3% | – | – | -540.7% | -122.2% | 118.2% | – | – | – |
| OCF / Net income | 0.67 | 0.72 | 0.83 | 0.92 | 0.90 | 1.70 | -1.83 | 0.89 | 0.72 | – |
| FCF / OCF | 100.7% | 129.8% | 111.6% | 109.6% | 103.8% | 114.8% | 96.9% | 102.6% | 112.7% | – |
| FCF / Net income | 0.67 | 0.93 | 0.93 | 1.01 | 0.93 | 1.96 | -1.77 | 0.91 | 0.81 | – |
| Unlevered free cash flow | -$79.08M | -$77.98M | -$75.12M | -$58.02M | -$78.37M | -$51.86M | $33.15M | -$17.46M | -$16.48M | – |
| Levered free cash flow | -$79.08M | -$77.98M | -$75.12M | -$58.78M | -$78.97M | -$51.86M | $33.15M | -$17.46M | -$16.48M | – |
| Efficiency | ||||||||||
| Asset turnover | 0.04 | 0.01 | 0.00 | 0.00 | 0.06 | 0.15 | 0.22 | – | – | – |
| Fixed asset turnover | 0.36 | 0.10 | 0.00 | 0.00 | 2.20 | 8.17 | 17.69 | – | – | – |
| CapEx to revenue | 8.1% | 788.3% | – | – | 20.7% | 18.0% | 3.7% | – | – | – |
| CapEx to OCF | -0.66% | -29.8% | -11.6% | -9.6% | -3.8% | -14.8% | 3.1% | -2.6% | -12.7% | – |
| Liquidity | ||||||||||
| Current ratio | 6.90 | 8.79 | 8.87 | 6.56 | 11.79 | 8.45 | 4.19 | 11.38 | – | – |
| Quick ratio | 6.90 | 8.79 | 8.87 | 6.56 | 11.79 | 8.45 | 4.19 | 11.38 | – | – |
| Cash ratio | 6.30 | 8.43 | 8.53 | 6.35 | 11.44 | 8.27 | 4.12 | 11.18 | – | – |
| Working capital | $70.44M | $116.57M | $153.25M | $48.38M | $123.32M | $198.43M | $168.58M | $39.16M | – | – |
| Net current asset value | $20.31M | $65.71M | $120.98M | $48.17M | $80.21M | $152.83M | $165.50M | $38.82M | – | – |
| Leverage | ||||||||||
| Total debt | – | – | – | $10.00M | $833.00K | – | $180.00K | $349.00K | – | – |
| Net debt | – | – | – | -$45.25M | -$129.87M | – | -$217.18M | -$41.84M | – | – |
| Debt / Equity | – | – | – | -0.10 | -0.02 | – | 0.00 | -0.01 | – | – |
| Debt ratio | – | – | – | 13.6% | 0.45% | – | 0.08% | 0.78% | – | – |
| Assets to equity | 2.21 | 1.41 | 1.30 | -0.74 | -4.39 | 1.38 | 1.33 | -0.92 | – | – |
| Long-term debt to assets | – | – | – | – | – | – | 0.08% | 0.78% | – | – |
| Long-term debt to equity | – | – | – | – | – | – | 0.00 | -0.01 | – | – |
| Total debt / Capitalization | – | – | – | -11.2% | -2.0% | – | 0.11% | -0.73% | – | – |
| Long-term debt / Capitalization | – | – | – | – | – | – | 0.11% | -0.73% | – | – |
| Cash flow to debt | – | – | – | -536.4% | -9,130.7% | – | 19,008.9% | -4,877.9% | – | – |
| Interest coverage | ||||||||||
| EBIT / Interest expense | – | – | – | -61.39 | -109.99 | – | – | – | – | – |
| Per share | ||||||||||
| Revenue per share | 0.68 | 0.24 | 0.00 | 0.00 | 52.84 | 141.56 | 122.00 | – | – | – |
| EPS (basic) | -12.48 | -9.37 | -53.08 | -227.42 | -321.10 | -106.60 | -297.70 | -1,628.90 | -3,742.70 | – |
| EPS (diluted) | -12.48 | -9.37 | -53.08 | -227.42 | -321.10 | -106.60 | -297.70 | -1,628.90 | -3,742.70 | – |
| Book value per share | 5.46 | 17.11 | 21.20 | -368.87 | -158.53 | 736.77 | 705.36 | -3,010.85 | -5,482.15 | – |
| Tangible book value per share | 5.46 | 17.11 | 21.20 | -368.87 | -158.53 | 736.77 | 705.36 | -3,010.85 | -5,482.15 | – |
| Cash per share | 7.98 | 13.45 | 20.73 | 205.79 | 490.94 | 843.37 | 916.09 | 2,630.89 | – | – |
| Operating cash flow per share | -8.34 | -6.41 | -8.39 | -199.82 | -285.68 | -172.96 | 144.21 | -1,061.61 | -2,702.79 | – |
| Free cash flow per share | -8.40 | -8.32 | -9.37 | -218.95 | -296.62 | -198.49 | 139.73 | -1,088.80 | -3,047.35 | – |
| CapEx per share | 0.06 | 1.91 | 0.98 | 19.13 | 10.95 | 25.53 | 4.48 | 27.19 | 344.55 | – |
| Valuation at period end | ||||||||||
| Market cap | $75.28M | $354.75M | $13.61M | $52.22M | $68.17M | $457.46M | $16.06M | – | – | – |
| Enterprise value | -$17.20M | $217.75M | -$28.11M | -$38.80M | -$79.90M | $233.23M | -$149.04M | – | – | – |
| P/S | 11.8x | 156x | – | – | 4.8x | 12.4x | 0.6x | – | – | – |
| P/B | 1.5x | 2.2x | 0.1x | -0.5x | -1.6x | 2.4x | 0.1x | – | – | – |
| P/TBV | 1.5x | 2.2x | 0.1x | -0.5x | -1.6x | 2.4x | 0.1x | – | – | – |
| P/OCF | -1.0x | -5.9x | -0.2x | -1.0x | -0.9x | -10.1x | 0.5x | – | – | – |
| P/FCF | – | – | – | – | – | – | 0.5x | – | – | – |
| EV/Sales | -2.7x | 95.9x | – | – | -5.7x | 6.3x | -5.1x | – | – | – |
| EV/EBIT | 0.1x | – | 0.3x | 0.7x | 1.0x | – | 7.2x | – | – | – |
| EV/OCF | 0.2x | -3.6x | 0.4x | 0.7x | 1.1x | -5.2x | -4.4x | – | – | – |
| EV/FCF | 0.2x | – | 0.4x | 0.7x | 1.0x | – | – | – | – | – |
| Earnings yield | -155.8% | -23.6% | -596.2% | -111.1% | -124.2% | -5.8% | -116.7% | – | – | – |
| FCF yield | -105.0% | -22.0% | -551.8% | -112.6% | -115.8% | -11.3% | 206.4% | – | – | – |
| Cost structure | ||||||||||
| R&D to revenue | 1,025.9% | 2,802.1% | – | – | 433.1% | 101.2% | 64.9% | – | – | – |
| Stock-based comp to revenue | 119.8% | 196.5% | – | – | 154.6% | 27.0% | 12.5% | – | – | – |
| Per employee | ||||||||||
| Total employees | 58 | 104 | 101 | 48 | 74 | 87 | 47 | 47 | 47 | 47 |
| Revenue per employee | $110.21K | $21.84K | – | $0 | $190.11K | $425.10K | $615.89K | – | – | – |
| Operating profit per employee | -$2.10M | -$883.75K | -$836.97K | -$1.23M | -$1.14M | -$316.67K | -$439.89K | -$403.06K | -$346.94K | – |
| Net income per employee | -$2.02M | -$803.66K | -$803.68K | -$1.21M | -$1.14M | -$304.72K | -$398.85K | -$407.83K | -$430.57K | – |
| Free cash flow per employee | -$1.36M | -$749.77K | -$743.75K | -$1.22M | -$1.07M | -$596.08K | $705.36K | -$371.49K | -$350.57K | – |
| Growth | ||||||||||
| Revenue 1Y growth | 181.5% | – | – | -100.0% | -62.0% | 27.8% | – | – | – | – |
| Revenue 3Y CAGR | – | -45.6% | – | – | – | – | – | – | – | – |
| Revenue 5Y CAGR | -29.6% | -39.9% | – | – | – | – | – | – | – | – |
| EBIT 1Y growth | -32.6% | -8.7% | -43.3% | 29.8% | -205.0% | -33.3% | -9.1% | -16.2% | – | – |
| Net income 1Y growth | -40.3% | -3.0% | -39.9% | 31.5% | -219.4% | -41.4% | 2.2% | 5.3% | – | – |
| Diluted EPS 1Y growth | -33.2% | 82.3% | 76.7% | 29.2% | -201.2% | 64.2% | 81.7% | 56.5% | – | – |
| Operating cash flow 1Y growth | -30.8% | 10.7% | -25.4% | 29.5% | -68.3% | -232.1% | 301.0% | -16.5% | – | – |
| Free cash flow 1Y growth | -1.4% | -3.8% | -27.8% | 25.6% | -52.3% | -256.4% | 289.9% | -6.0% | – | – |
| CapEx 1Y growth | -97.1% | 128.5% | 52.6% | 76.3% | -56.3% | 527.0% | 144.0% | -76.6% | – | – |
| CapEx 3Y CAGR | -53.5% | 83.1% | 5.5% | 69.0% | 88.4% | 53.0% | – | – | – | – |
| CapEx 5Y CAGR | -40.0% | 75.9% | 78.2% | 22.5% | – | – | – | – | – | – |
| Total assets 1Y growth | -49.8% | 2.1% | 200.6% | -60.2% | -30.0% | 18.6% | 401.1% | – | – | – |
| Total assets 3Y CAGR | 15.5% | 6.9% | -5.7% | -30.9% | 60.8% | – | – | – | – | – |
| Total assets 5Y CAGR | -15.6% | 0.27% | 37.8% | – | – | – | – | – | – | – |
Every figure here is calculated from standardized financial statements — hover a row name for the formula — not reported by the company. Valuation multiples use the closing price at the end of that period, not today's price.